CITA NEUROPHARMACEUTICALS Trademark

Trademark Overview

On Thursday, August 11, 2005, a trademark application was filed for CITA NEUROPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the CITA NEUROPHARMACEUTICALS trademark a serial number of 78690387. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 8, 2015. This trademark is owned by Cita Neuropharmaceuticals Inc.. The CITA NEUROPHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services in the field of pharmaceuticals, namely, research and development commercialization in the field of neurology and pain; pharmaceutical development, consulting, screening and clinical research services
cita neuropharmaceuticals

General Information

Serial Number78690387
Word MarkCITA NEUROPHARMACEUTICALS
Filing DateThursday, August 11, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 8, 2015
Registration Number3512543
Registration DateTuesday, October 7, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2007

Trademark Statements

Disclaimer with Predetermined Text"NEUROPHARMACEUTICALS"
Goods and ServicesResearch services in the field of pharmaceuticals, namely, research and development commercialization in the field of neurology and pain; pharmaceutical development, consulting, screening and clinical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 8, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCita Neuropharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga L5L 1J9
CA
Party NameCita Neuropharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga L5L 1J9
CA
Party NameCita Neuropharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga L5L 1J9
CA

Trademark Events

Event DateEvent Description
Friday, May 8, 2015CANCELLED SEC. 8 (6-YR)
Wednesday, September 1, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 7, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, September 2, 20081(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, August 29, 2008NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 2, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 29, 2008TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, March 4, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2007NOTICE OF PUBLICATION
Monday, November 5, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 2, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 1, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 1, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 1, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 10, 2007NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, June 10, 2007INQUIRY TO SUSPENSION E-MAILED
Sunday, June 10, 2007SUSPENSION INQUIRY WRITTEN
Tuesday, April 10, 2007LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, April 5, 2007ASSIGNED TO LIE
Monday, September 18, 2006LETTER OF SUSPENSION E-MAILED
Monday, September 18, 2006SUSPENSION LETTER WRITTEN
Wednesday, September 6, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 1, 2006NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2006NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2006ASSIGNED TO EXAMINER
Wednesday, August 17, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuropharmaceuticals cita research development field services consulting clinical pharmaceutical screening commercialization pharmaceuticals